Cristina Borras, Director of Internationalization at AGAUR, and Pastora Martínez, Manager of IDIBAPS, welcomed the attendees highlighting, first, data on the Catalan participation in previous framework programme and, secondly, the profile of those attending the conference as well as its experience in Horizon 2020.
After the welcome, Marta Gómez Quintanilla (CDTI), Spanish representative in the program committee of the European Commission's Social Challenge 1 and the Innovative Medicines Initiative (IMI), presented the European landscape of health, the several existing funding opportunities, such as IMI2 programme, the expected timeline for 2016-2017 calls and the importance of influencing the definition of the European priorities.
David Rovirosa, Head of R&D International Innovation at ACCIÓ, presented the two instruments of the RIS3Cat (Catalonia’s Smart Specialisation Strategy) that will be managed from his agency: RIS3Cat Communities and Nuclis d’Innovació Tecnològica. These regional schemesreceive funding from the European structural funds FEDER. He also introduced the support options offered by the Enterprise Europe Network (EEN) to Catalan Small and Medium Enterprises (SME) to have access to international business opportunities and funding programs for R&D in Europe.
Attendees had the opportunity to exchange opinions and clarify doubts with both Marta Gómez Quintanilla and David Rovirosa. With this conference, it is expected that the participating institutions will develop a better strategy for their participation in European health calls to obtain greater success in attracting resources from the European Commission.
This conference has been supported by the SIMPACT project, funded by the Ministry of Economy and Competitiveness (MINECO).
- Marta Gómez Quintanilla (Representantative in Social Challenge 1 and IMI, H2020, CDTI)
- David Rovirosa (Head of R&D International Innovation, ACCIÓ)